Thioguanine from Canada
Thioguanine (6-TG) is a guanine analog chemotherapy drug containing fused purine heterocycle with sulfur substitution, used for acute myeloid leukemia. Classified HTS 2934.99.4700 as heterocyclic drug per numerical order rule over organo-sulfur heading 2930. Chemically defined active pharmaceutical ingredient.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.6096.3%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• NCI Investigational Drug Branch clearance if research grade; sulfur odor containment packaging; TPMT genotyping documentation recommended